Talking Nutrition, Health & Care

Our latest articles, covering industry news, new science, consumer insights and more.

Subscribe to our newsletter

Featured story

Discover our new portfolio of taste solutions for pharmaceutical formulations

The demand for patient-friendly medications is growing. Pill fatigue, dysphagia, and taste aversion may impact patient compliance to medication, prompting drug developers to rethink existing or create new formulations that are both effective and palatable.

In response, dsm-firmenich has launched a new portfolio of taste solutions designed specifically for pharmaceutical applications, helping manufacturers to overcome common taste and sensory challenges.

Read more

Latest articles

Segments
Products
    • Show more
    • Show less
Customized solutions
Expert services
Health benefits
    • Show more
    • Show less
All filters
Reset filters
  • The gut microbiome as a pathway to supporting children with autism: New study reveals synbiotics' dual benefits for digestive and behavioral symptoms

    2 April 2025

    The gut microbiome as a pathway to supporting children with autism: New study reveals synbiotics' dual benefits for digestive and behavioral symptoms

    Read more
  • Turn the tide against global malnutrition: The importance of cross-sector collaboration

    31 March 2025

    Turn the tide against global malnutrition: The importance of cross-sector collaboration

    Read more
  • Introducing dsm-firmenich’s new portfolio of taste solutions for pharmaceutical formulations

    24 March 2025

    Introducing dsm-firmenich’s new portfolio of taste solutions for pharmaceutical formulations

    Read more
  • What's next for gut health? 5 breakthrough trends from Probiota 2025

    11 March 2025

    What's next for gut health? 5 breakthrough trends from Probiota 2025

    Read more
  • New CBD bioavailability study with CBtru®

    21 February 2025

    New CBD bioavailability study with CBtru®

    Read more
  • Unlock mineral bioavailability: How phytase breaks through absorption barriers

    12 February 2025

    Unlock mineral bioavailability: How phytase breaks through absorption barriers

    Read more
  • Ask-the-Expert: Explore a new human milk oligosaccharide (HMO) review revealing how HMO combinations can support infant health

    31 January 2025

    Ask-the-Expert: Explore a new human milk oligosaccharide (HMO) review revealing how HMO combinations can support infant health

    Read more
  • Scientific innovation based on natural inspiration: Emerging trends in early life nutrition

    16 January 2025

    Scientific innovation based on natural inspiration: Emerging trends in early life nutrition

    Read more
  • Insights from a surgeon: How can omega-3s elevate perioperative nutrition?

    10 January 2025

    Insights from a surgeon: How can omega-3s elevate perioperative nutrition?

    Read more
  • What does the latest gut health research tell us about Humiome® B2’s potential for a healthy gut microbiome? Ask the scientist

    18 December 2024

    What does the latest gut health research tell us about Humiome® B2’s potential for a healthy gut microbiome? Ask the scientist

    Read more
Latest Press Releases

  • 29 April 2025

    Synbiotics emerge as promising tool for managing extreme fatigue and post-exercise malaise, clinical trial suggests

    New clinical evidence highlights potential of three-month synbiotic supplementation in attenuating post-exercise malaise and increasing brain metabolites in adults with post-COVID-19 chronic fatigue syndrome (CFS).

    Learn more

  • 14 April 2025

    From cellular aging to gut microbiome: dsm-firmenich highlights solutions to advance nutrition at Vitafoods 2025

    dsm-firmenich, a leading innovator in health, nutrition and beauty, is set to showcase solutions that advance nutrition at Vitafoods Europe 2025 on booth 3G58 with a display of its latest innovations in healthy longevity, gut health and more.

    Learn more

  • 11 April 2025

    Boost for infant health: India approves dsm-firmenich's 2'-FL HMO

    dsm-firmenich, a global innovator in health, nutrition and beauty, has today announced the approval of its human milk oligosaccharide (HMO), 2'-O-Fucosyllactose (2'-FL)—commercially known as GLYCARE® 2FL—as a functional ingredient for early life nutrition in India. This regulatory milestone marks a new opportunity to enhance infant health, as well as support HMO innovation in the region, with GLYCARE® 2FL representing dsm-firmenich’s first HMO approval in India.

    Learn more
All press releases

Sign up for our newsletter

Stay up-to-date on the latest science, events, industry news and market trends from dsm-firmenich Health, Nutrition & Care.
Subscribe

How can we help you?

  • New partnership request

    Have an idea for a new project, a groundbreaking innovation, or a need for expert services? Let’s talk.

  • Sample request

    Don’t just take our word for it. Discover how our solutions can support your product development journey. 

  • Quote request

    Tell us about your project needs. We’ll build you a tailored quote.

Quick links

Premix solutions

Customized blends of functional ingredients in one single, efficient premix.

Market-ready solutions

Streamline your product development process and get to market faster.

Events

From trade shows to conferences and other industry events, find out where you can meet us next.

Talking Nutrition, Health & Care

Explore new science, consumer insights, industry news and more in our latest articles.

Knowledge center

Discover educational whitepapers, webinars, publications and technical information.

Customer Portal

Request samples, place orders and view product documentation.